Antipsychotic discontinuation: mind the patient and the real-world evidence

Jurjen J. Luykx; Jari Tiihonen

doi:10.1016/S2215-0366(21)00159-0

Antipsychotic discontinuation: mind the patient and the real-world evidence

Jurjen J. Luykx
, Jari Tiihonen

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Citation (Scopus)

3 Downloads (Pure)

Original language	English
Pages (from-to)	555-557
Number of pages	3
Journal	The Lancet Psychiatry
Volume	8
Issue number	7
DOIs	https://doi.org/10.1016/S2215-0366(21)00159-0
Publication status	Published - Jul 2021

Access to Document

10.1016/S2215-0366(21)00159-0

1-s2.0-S2215036621001590-mainFinal published version, 60.3 KBLicence: Taverne

Cite this

@article{495204fe46924deab97e53607e7223ea,

title = "Antipsychotic discontinuation: mind the patient and the real-world evidence",

author = "Luykx, \{Jurjen J.\} and Jari Tiihonen",

note = "Funding Information: JT has participated in research projects funded by grants from Janssen-Cilag and Eli Lilly, reports personal fees from the Finnish Medicines Agency, European Medicines Agency, Eli Lilly, Janssen-Cilag, Lundbeck, and Otsuka, grants from the Stanley Foundation and Sigrid Jus{\'e}lius Foundation, and is a member of the advisory board for Lundbeck. JJL declares no competing interests.",

year = "2021",

month = jul,

doi = "10.1016/S2215-0366(21)00159-0",

language = "English",

volume = "8",

pages = "555--557",

journal = "The Lancet Psychiatry",

issn = "2215-0366",

publisher = "Elsevier Limited",

number = "7",

}

TY - JOUR

T1 - Antipsychotic discontinuation

T2 - mind the patient and the real-world evidence

AU - Luykx, Jurjen J.

AU - Tiihonen, Jari

N1 - Funding Information: JT has participated in research projects funded by grants from Janssen-Cilag and Eli Lilly, reports personal fees from the Finnish Medicines Agency, European Medicines Agency, Eli Lilly, Janssen-Cilag, Lundbeck, and Otsuka, grants from the Stanley Foundation and Sigrid Jusélius Foundation, and is a member of the advisory board for Lundbeck. JJL declares no competing interests.

PY - 2021/7

Y1 - 2021/7

UR - https://www.scopus.com/pages/publications/85108073064

U2 - 10.1016/S2215-0366(21)00159-0

DO - 10.1016/S2215-0366(21)00159-0

M3 - Comment/Letter to the editor

C2 - 33930316

AN - SCOPUS:85108073064

SN - 2215-0366

VL - 8

SP - 555

EP - 557

JO - The Lancet Psychiatry

JF - The Lancet Psychiatry

IS - 7

ER -

Antipsychotic discontinuation: mind the patient and the real-world evidence

Access to Document

Other files and links

Cite this